Swiss regulator approves blood safety system from Cerus

08/19/2009 | Reuters

Swissmedic granted approval to Cerus' Intercept blood system, which inactivates viruses, bacteria and other blood-borne pathogens in blood components used for transfusion. The company said the approval allows Intercept-treated platelets to be stored for a week.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ